-
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Rating of "Moderate Buy" by Analysts
ソース: Buzz FX / 21 2 2025 02:36:12 America/New_York
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat February 21, 2025 Share Link copied to clipboard. Shares of Iovance Biotherapeutics, Inc.
Read more...